40 results on '"Orio, P.F."'
Search Results
2. Clinical Presentation and Management of Prostate Cancer in the Middle East
3. Prostate Cancer Awareness in the Middle East
4. Association between Artificial Intelligence-Derived Tumor Volume and Oncologic Outcomes for Localized Prostate Cancer Treated with Radiation Therapy
5. Characterizing the Performance of a Deep-Learning Segmentation Algorithm for Outlining Dominant Intraprostatic Lesions on Prostate Multi-Parametric MRI
6. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study
7. Can Perirectal Spacing Help Reduce GI Toxicity in Patients Undergoing Post-Prostatectomy Radiotherapy?
8. Association Between Treatment Modality and Probability of Second Malignancy in Localized Prostate Cancer Patients
9. Could an Academic Review of Pathology Lead to Changes in Patient Care in Men With Prostate Cancer?
10. Comparison of Cost vs. Reimbursement for Definitive Radiotherapy in Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing
11. Development & Impact of a Virtual PSA Monitoring Clinic for Follow-up of Prostate Cancer Patients: An Efficient Model With Unique Benefits Relevant to COVID-19
12. OC-1027: Comparing GU toxicity of LDR I-125 prostate brachytherapy by robotic and manual loading techniques
13. Prospective Peer Review for Patients Undergoing Stereotactic Body Radiation Therapy and Intracranial Radiosurgery in a Multi-Site Community-Setting is Both Feasible and Effective
14. Association Between Percentage of Positive Biopsy Cores and Risk of Pelvic Lymph Node Involvement in Prostate Cancer
15. Impact of Prostate-Directed Radiation Therapy on Overall Survival for Patients with M1a Prostate Cancer
16. Enzalutamide Monotherapy with EBRT for Intermediate Risk Prostate Cancer. A Phase 2 Study
17. Combined External Beam Radiation Therapy and Brachytherapy Versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer
18. Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Brachytherapy Boost
19. Virtual PSA Monitoring Program Pilot: The Integration of Technology in Post Treatment Prostate Cancer Patient Care to Optimize Workflow and Increase Access to Care
20. Recent Trends in the Use of Androgen Deprivation Therapy with External Beam Radiation Therapy for Patients with Intermediate- and High-Risk Prostate Cancer
21. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer
22. PSA Velocity before Biochemical Failure is Associated with Distant Metastasis after Partial Prostate Treatment with Brachytherapy
23. Impact of Percent Positive Biopsy Cores on Cancer-Specific Mortality for Patients with High-Risk Prostate Cancer
24. Supplemental Androgen Deprivation Therapy Is More Beneficial Than Supplemental External Beam Radiation Therapy for Men with Unfavorable Intermediate Risk Prostate Cancer Treated with Brachytherapy
25. Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen
26. Low Rates of Androgen Deprivation Therapy Use With Salvage Radiation Therapy in Prostate Cancer Patients After Radical Prostatectomy
27. Incidence and Predictors of Upgrading and Upstaging Among 10,000 Patients with Gleason 3+4 Favorable Intermediate-Risk Prostate Cancer: Implications for Active Surveillance
28. Regional Dose Shaping for Low-Dose-Rate Brachytherapy Inverse Treatment Planning
29. Trends and Clinico-Sociodemographic Determinants of Stereotactic Body Radiation Therapy Use for Localized Prostate Cancer
30. Association with Distance to Treatment Facility and Treatment Trends: Implications for Radiation Reimbursement Policies
31. National Trends in Androgen Deprivation Therapy Use for Prostate Cancer After Versus Before the Controversy Surrounding Cardiovascular Toxicity
32. Adverse Pathologic Features Following Prostatectomy for Favorable High-Risk Versus Other High-Risk Prostate Cancer: Implications for Choice of Local Therapy
33. Shifting Brachytherapy Monotherapy Case Mix Toward Intermediate-Risk Prostate Cancer: Implications for Future Directions of Research
34. The Treatment of Thyroid Cancer With Fast Neutron Radiation Therapy: A 30-Year Institutional Experience
35. Incidence and determinants of 1-month mortality after cancer-directed surgery
36. Post-Treatment Prostate-Specific Antigen Nadir is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial
37. HDR-Emulating LDR Prostate (HELP) Brachytherapy Utilizing Needle Optimized Inverse Planned Intraoperative Isotope Delivery
38. 102
39. 20 Gy Versus 44 Gy Supplemental Beam Radiation with Pd-103 Prostate Brachytherapy: Early Biochemical Outcomes From a Prospective Randomized Multi-Center Trial
40. 102: 15-Year Biochemical Relapse Free Survival in Clinical Stage T1-T3 Prostate Cancer Following Combined External Beam Radiotherapy and Brachytherapy: Seattle Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.